A company has been approved to manufacture and sell the new drug, Acelex Cap, for the first time ever without any manufacturing facility

Published: 2015-02-09 13:51:00

Updated: 2015-02-09 13:51:00

The Ministry of Food and Drug Safety (Minister Seung Jung) announced on the 5^th to approve manufacturing and sales of the 22^nd domestically developed new drug ‘Acelex Cap’ of CrystalGenomics.

‘Acelex Cap’, having ‘Polmacoxib’as a main component, is an anti-inflammatory agent to relax symptoms of osteoarthritis patients, which decreased the gastrointestinal side effect compared to the existing ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.